Boumah C E, Hogue D L, Cass C E
Department of Biochemistry, University of Alberta, Edmonton, Canada.
Biochem J. 1992 Dec 15;288 ( Pt 3)(Pt 3):987-96. doi: 10.1042/bj2880987.
We have examined binding of [3H]nitrobenzylthioinosine (NBMPR) and influx of [3H]thymidine in adherent cultures of human choriocarcinoma (BeWo) cells and, for comparison, cervical-carcinoma (HeLa) cells. Specific association of NBMPR with BeWo cells at 22 degrees C required 1.5 h to reach an equilibrium between free and bound ligand, whereas association with HeLa cells required 20-30 min. Scatchard analysis of NBMPR binding to low-density cultures of BeWo cells revealed a total of 27 x 10(6) sites per cell, consisting of two distinct populations that differed in their affinities for NBMPR. One population bound NBMPR with 'high' affinity (Bmax.1 15.0 pmol/10(6) cells; Kd1 0.6 nM) and the other, larger, population bound NBMPR with 'low' affinity (Bmax.2 29.0 pmol/10(6) cells; Kd2 14.5 nM). By contrast, HeLa cells possessed only 4.1 x 10(5) sites per cell, and these sites all bound NBMPR with the same affinity (Bmax. 0.7 pmol/10(6) cells; Kd 0.5 nM). Interaction of NBMPR with both populations of sites in BeWo cells could be blocked by nitrobenzylthioguanosine (NBTGR), dilazep or dipyridamole. Concentration-effect relationships for dilazep inhibition of binding of 1 nM- and 25 nM-NBMPR to BeWo cells were monophasic, with virtually complete inhibition achieved at 0.1 microM and 1 microM respectively. Plasma-membrane preparations from BeWo cells also had high numbers of NBMPR-binding sites, and u.v. irradiation of site-bound [3H]NBMPR in such preparations labelled polypeptides that migrated in electrophoretograms as a broad band with a peak M(r) of 60,000. The concentration-effect relationship for NBMPR inhibition of thymidine transport by BeWo cells was biphasic, with an IC50 for inhibition of the 'NBMPR-sensitive' component of 1.6 nM and a substantial (15-20%) component of flux that was not inhibited by 10 microM-NBMPR and was thus 'NBMPR-insensitive'. Vmax. values for thymidine transport by BeWo cells were 20-30-fold larger than the corresponding values for transport by HeLa cells. Elimination of the Na+ gradient had no effect on initial rates of thymidine fluxes measured in either the presence or the absence of NBMPR. Our results demonstrate that BeWo cells have an unusually large capacity for NBMPR-sensitive nucleoside transport, apparently resulting from high levels of expression of 'erythrocyte-like' transport elements, identified by their high-affinity interaction with NBMPR. The relationship of the low-affinity binding sites to NBMPR-sensitive transporter elements is uncertain.
我们检测了[3H]硝基苄硫基肌苷(NBMPR)与人绒毛膜癌(BeWo)细胞贴壁培养物的结合以及[3H]胸苷的摄取,并以宫颈癌(HeLa)细胞作为对照。在22℃时,NBMPR与BeWo细胞的特异性结合需要1.5小时才能使游离配体与结合配体达到平衡,而与HeLa细胞的结合则需要20 - 30分钟。对低密度培养的BeWo细胞进行的NBMPR结合的Scatchard分析显示,每个细胞共有27×10⁶个位点,由对NBMPR亲和力不同的两个不同群体组成。一个群体以“高”亲和力结合NBMPR(Bmax.1为15.0 pmol/10⁶个细胞;Kd1为0.6 nM),另一个较大的群体以“低”亲和力结合NBMPR(Bmax.2为29.0 pmol/10⁶个细胞;Kd2为14.5 nM)。相比之下,HeLa细胞每个细胞仅拥有4.1×10⁵个位点,并且这些位点都以相同的亲和力结合NBMPR(Bmax为0.7 pmol/10⁶个细胞;Kd为0.5 nM)。NBMPR与BeWo细胞中两个位点群体的相互作用均可被硝基苄硫基鸟苷(NBTGR)、双嘧达莫或潘生丁阻断。双嘧达莫对1 nM和25 nM - NBMPR与BeWo细胞结合的抑制作用的浓度 - 效应关系是单相的,分别在0.1 μM和1 μM时几乎完全抑制。BeWo细胞的质膜制剂也有大量的NBMPR结合位点,并且在此类制剂中对结合位点上的[3H]NBMPR进行紫外线照射标记的多肽,在电泳图谱中迁移为一条宽带,峰值相对分子质量为60,000。NBMPR对BeWo细胞胸苷转运的抑制作用的浓度 - 效应关系是双相的,对“NBMPR敏感”成分抑制的IC50为1.6 nM,并且有相当一部分(15 - 20%)的通量不受10 μM - NBMPR的抑制,因此是“NBMPR不敏感”的。BeWo细胞胸苷转运的Vmax值比HeLa细胞转运的相应值大20 - 30倍。消除Na⁺梯度对在有或没有NBMPR存在的情况下测量的胸苷通量的初始速率均无影响。我们的结果表明,BeWo细胞对NBMPR敏感的核苷转运具有异常大的能力,这显然是由于高水平表达的“类红细胞”转运元件所致,这些元件通过它们与NBMPR的高亲和力相互作用得以识别。低亲和力结合位点与NBMPR敏感转运元件之间的关系尚不确定。